Use of US Food and Drug Administration expedited drug development and review programs by orphan and nonorphan novel drugs approved from 2008 to 2021 (vol 5, e2239336, 2022)A. N. Monge,D. W. Sigelman,R. J. Temple,H. S. ChahalJAMA NETWORK OPEN（2023）引用 7|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
